Neuroliten MVP System Clinical Observation Study
Details
Age
Adult
Eligibility
1. Male and female subjects ages 18 – 75. 2. Intractable or refractory epilepsy with at least 2 seizures/week. 3. Have caregiver who stays with the patient and can provide information about the seizures. 4. Have implanted vagus nerve stimulation (VNS). 5. Have a working Apple iPhone.
Type of Study
Treatment
Scope
Local
Locations
Harmony Campus
Medical Center of the Rockies
Principal Investigator
Barbara Hager, MD
Study ID
Protocol Number: 22-1062
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers